ARWR — Arrowhead Pharmaceuticals Inc. price, chart and key statistics

Price data

Price

$64.19

Change YTD

-3.31%

Next earnings

Nov 24, 2026

Market cap

9.1B2016-12 115M2026-10 9.1B+7785.4% over the window

Enterprise value

7.5B

Shares outstanding

141.3M2016-06 60.8M2026-06 141.3M+132.5% over the window

52W low

$34.47

52W high

$95.49

From 52W high

-32.78%

From 52W low

+86.22%

52W range

49%

Beta

1.27

Volume

Rel volume

0.76×

30D volume

2M

30D $ vol

144.6M

Insider trading

Insider net 1WNo open-market insider purchase or sale with a transaction date in the last 7 days, as filed on Form 4.

none

Insider net 1MNo open-market insider purchase or sale with a transaction date in the last 30 days, as filed on Form 4.

none

Insider net 3M0 insider-days of buying (no priced lot) and 2 of selling ($1.2M) in the last 91 days, by transaction date, open-market transactions only — awards, exercises, tax withholding and employee-plan purchases are not counted. A Form 4 is filed within two business days of the trade, so the newest days may not be in yet.

−$1.2M

Insider net 1Y0 insider-days of buying (no priced lot) and 9 of selling ($10.3M) in the last 365 days, by transaction date, open-market transactions only — awards, exercises, tax withholding and employee-plan purchases are not counted. A Form 4 is filed within two business days of the trade, so the newest days may not be in yet.

−$10.3M

Form 4 transactions by trade date, as filed; latest on file 2026-08-18.

Fundamentals

Sales (ttm)

669.5M2016-06 170.8K2026-06 669.5M+391800.3% over the window

Sales/share

$4.742016-06 $0.002026-06 $4.74+168447.4% over the window

EPS (ttm)

-$2.282017-09 -$0.472026-06 -$2.28+385.0% over the window

FCF (ttm)

-75.1M2016-06 -68.2M2026-06 -75.1M+10.1% over the window

FCF/share

-$0.532016-06 -$1.122026-06 -$0.53-52.7% over the window

Book value/share

$3.302016-06 $0.992026-06 $3.30+233.8% over the window

Net margin

-47.79%2016-06 -49315.2%2026-06 -47.8%-99.9% over the window

ROE

-68.73%2016-06 -140.5%2026-06 -68.7%-51.1% over the window

ROA

-15.15%2016-06 -98.5%2026-06 -15.1%-84.6% over the window

Current ratio

5.902016-06 3.342026-06 5.90+76.5% over the window

Growth (CAGR, ttm) · 10Y

Sales

+16.86%2025-06-30 → 2026-06-30573M → 669.5M (+16.8% total)+37.73%2023-06-30 → 2026-06-30256.2M → 669.5M (+161.3% total)+44.14%2021-06-30 → 2026-06-30107.6M → 669.5M (+522.0% total)+128.75%2016-06-30 → 2026-06-30170.8K → 669.5M (+391800.3% total)

Shares

+2.17%2025-06-30 → 2026-06-30138.3M → 141.3M (+2.2% total)+9.63%2023-06-30 → 2026-06-30107.2M → 141.3M (+31.8% total)+6.26%2021-06-30 → 2026-06-30104.3M → 141.3M (+35.5% total)+8.81%2016-06-30 → 2026-06-3060.8M → 141.3M (+132.5% total)

Per-share growth (CAGR, ttm) · 10Y

Sales/share

+14.38%2025-06-30 → 2026-06-30$4.14 → $4.74 (+14.4% total)+25.63%2023-06-30 → 2026-06-30$2.39 → $4.74 (+98.3% total)+35.64%2021-06-30 → 2026-06-30$1.03 → $4.74 (+359.1% total)+110.24%2016-06-30 → 2026-06-30$0.00 → $4.74 (+168447.4% total)

Book value/share

-12.77%2025-06-30 → 2026-06-30$3.78 → $3.30 (-12.8% total)-1.07%2023-06-30 → 2026-06-30$3.40 → $3.30 (-3.2% total)-4.69%2021-06-30 → 2026-06-30$4.19 → $3.30 (-21.4% total)+12.81%2016-06-30 → 2026-06-30$0.99 → $3.30 (+233.8% total)

Price

+85.60%2025-10-02 → 2026-10-02$34.60 → $64.19 (+85.5% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+34.72%2023-10-02 → 2026-10-02$26.25 → $64.19 (+144.5% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+0.50%2021-10-01 → 2026-10-02$62.60 → $64.19 (+2.5% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+24.19%2016-09-30 → 2026-10-02$7.35 → $64.19 (+773.3% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.

Total return

+85.60%2025-10-02 → 2026-10-02$34.60 → $64.19 (+85.5% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+34.72%2023-10-02 → 2026-10-02$26.25 → $64.19 (+144.5% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+0.50%2021-10-01 → 2026-10-02$62.60 → $64.19 (+2.5% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+24.19%2016-09-30 → 2026-10-02$7.35 → $64.19 (+773.3% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.

-28.2×2016-12 -1.412026-10 -28.33+1914.1% over the window

Fwd P/E

-13.4×

P/S (ttm)Market cap ÷ TTM revenue.

13.5×2016-12 726.122026-10 13.54-98.1% over the window

P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.

19.5×2016-12 1.202026-10 19.47+1519.0% over the window

EV/Sales (ttm)

11.3×

FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.

-0.83%2016-09 -59.4%2026-06 -0.7%-98.9% over the window

Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 141.3M ÷ 138.3M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.

-2.17%

Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-2.17%) + dividends paid over that year ($0) ÷ market_cap_at(2025-06-30) ($2.2B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.

-2.17%

Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($0) ÷ today's market cap ($9.1B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.

0.00%2016-09 -45.4%2026-06 0.0%-100.0% over the window

Shareholder yield (cash, ttm)(TTM buybacks net of issuance $0 + TTM dividends $0) ÷ today's market cap ($9.1B). Same caveat as the cash buyback yield.

0.00%2016-09 -45.4%2026-06 0.0%-100.0% over the window

Vs own 10Y history

P/S

26th

P/B

90th